United Therapeutics CorporationUTHRNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+16.5%
5Y CAGR+9.3%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+16.5%/yr
vs +19.0%/yr prior
5Y CAGR
+9.3%/yr
Recent acceleration
Acceleration
-2.5pp
Decelerating
Percentile
P90
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.19% |
| Q3 2025 | -7.04% |
| Q2 2025 | 2.12% |
| Q1 2025 | 5.16% |
| Q4 2024 | 3.38% |
| Q3 2024 | 5.95% |
| Q2 2024 | 3.51% |
| Q1 2024 | -9.37% |
| Q4 2023 | 2.04% |
| Q3 2023 | 5.12% |
| Q2 2023 | 5.28% |
| Q1 2023 | 4.99% |
| Q4 2022 | 4.55% |
| Q3 2022 | 4.30% |
| Q2 2022 | 3.42% |
| Q1 2022 | 3.69% |
| Q4 2021 | 2.38% |
| Q3 2021 | 4.21% |
| Q2 2021 | 4.39% |
| Q1 2021 | 0.56% |
| Q4 2020 | 4.62% |
| Q3 2020 | 4.55% |
| Q2 2020 | 4.81% |
| Q1 2020 | 2.87% |
| Q4 2019 | -2.16% |
| Q3 2019 | 2.58% |
| Q2 2019 | 4.62% |
| Q1 2019 | 9.58% |
| Q4 2018 | -0.33% |
| Q3 2018 | 5.15% |
| Q2 2018 | 7.44% |
| Q1 2018 | 4.89% |
| Q4 2017 | -1.93% |
| Q3 2017 | 9.08% |
| Q2 2017 | 5.08% |
| Q1 2017 | 10.14% |
| Q4 2016 | 2.49% |
| Q3 2016 | 3.08% |
| Q2 2016 | 0.43% |
| Q1 2016 | 0.35% |